Louisiana Lawmakers to Address Drug Makers’ and PBMs’ 340B Policies in Thursday Hearing

Louisiana state capitol
A Louisiana House committee is considering a bill to stop drug manufacturers from impeding 340B covered entities’ use of contract pharmacies.

A hearing is set for Thursday in the Louisiana House on a bill to stop drug manufacturers from impeding 340B covered entities’ use of contract pharmacies.

State Rep. Chris Turner (R) introduced House Bill 548, the Defending Affordable Prescription

Read More »

New York State Allots $9 Million in Relief for RWCs Hurt by Medicaid Drug Benefit Transfer but No Funding So Far For Other 340B Entities

Mike Lee gesturing in a meeting
Mike Lee (center) of Evergreen Health says the unexplained inclusion of $9 million in supplemental aid for Ryan White clinics in New York state interim budget legislation "just shows the chaos" of New York's transfer of Medicaid managed care drug benefits to Medicaid fee for service.

The New York legislature on Monday passed a short-term state funding bill with $9 million in supplemental aid for Ryan White clinics that are losing 340B revenue due to the April 1 transfer of the state’s Medicaid managed care drug

Read More »

Maine Becomes Fourth State to Introduce 340B Hospital Transparency Bill

Aerial view of Maine state capitol
A bill in Maine would impose significant 340B program reporting requirements on hospitals.

Maine state senators have introduced a bill to require 340B hospitals to file annual reports with detailed information on the savings they receive through 340B drug discounts, including annual 340B revenue the hospital generates minus 340B aggregate acquisition costs, and

Read More »

New York Implements Medicaid Drug Benefits Transfer, 340B Entities Say Fight Isn’t Over

New York Gov. Kathy Hochul addressing the press
New York state 340B providers say they still hope Gov. Kathy Hochul (D) can be persuaded to embrace an alternative to the state's transfer of Medicaid managed care drug benefits to Medicaid fee for service.

New York state on Saturday transferred Medicaid managed care drug benefits to Medicaid fee for service. Health centers and Ryan White clinics have vowed to keep fighting the change, which they say will cost them millions of dollars in 340B

Read More »

New Mexico Passes 340B Anti-Discrimination Bill, After Dropping 340B Contract Pharmacy Provisions

New Mexico state capitol building
New Mexico lawmakers passed a bill to stop pharmacy benefit managers from discriminating against 340B providers, but stripped it of language that would have outlawed drug manufacturers’ conditions on 340B sales when entities use contract pharmacies.

With just minutes to go in this year’s session, New Mexico lawmakers recently passed a bill to stop pharmacy benefit managers from discriminating against 340B providers including reimbursing them at a lower rate than other providers. Gov. Michelle Lujan Grisham

Read More »

As April 1 Deadline Looms, NY Health Centers Urge Courts to Stop Medicaid Pharmacy Benefit Transfer

340B program advocates hold a die-in outside New York Gov. Kathy Hochul's office
New York state Sen. Robert Jackson (center, holding green sign) participated in a "die-in" outside of Gov. Kathy Hochul's office on Tuesday to protest the scheduled transfer of Medicaid managed care drug benefits to Medicaid fee for service on Saturday.

If New York State transfers Medicaid managed care drug benefits to Medicaid fee for service on Saturday as scheduled, “it will all but eliminate the savings that safety-net providers have realized through the 340B program and the revenues on which

Read More »

N.Y. State Health Centers Sue to Stop April 1 Shift of Medicaid Managed Care Drug Benefits to Fee for Service

Evergreen Health wordmark
Buffalo, N.Y.-based health center Evergreen Health and Harlem, N.Y.-based health health center Heritage Health and Housing asked a state court to halt Saturday's scheduled transfer of Medicaid drug benefits from managed care to fee for service.

The clock is ticking down in New York state to the scheduled April 1 transfer of Medicaid managed care drug benefits to Medicaid fee for service—a move that 340B safety net providers say would result in financial disaster.

Evergreen Health,

Read More »

HRSA Posts Two Drug Manufacturer Notices to 340B Entities

Vtama pharmaceutical product tube
Dermavant Sciences is giving refunds to health care providers that paid above the 340B ceiling price for Vtama, a treatment for plaque psoriasis.

Biopharmaceutical company Dermavant Sciences is giving refunds to health care providers that paid above the 340B ceiling price for Vtama, a non-steroidal cream to treat plaque psoriasis.

The U.S. Health Resources and Services Administration posted Dermavant’s notice to 340B covered

Read More »

Texas House Bill Addresses Medicaid MCO Bias Against 340B Pharmacies

Texas state capitol building with United States and Texas state flags
A bill in Texas would stop Medicaid MCOs and their PBMs from paying less than what Texas Medicaid pays for 340B-obtained drugs.

A bill has been introduced in Texas to stop Medicaid managed care organizations and their pharmacy benefit managers from reimbursing pharmacies for 340B-acquired drugs at less than what Texas Medicaid pays for the same 340B drugs.

Texas House Bill 1293

Read More »

CMS Announces First Drugs Subject to Medicare Inflation Rebates, Issues Guidance Addressing 340B and Medicare Negotiated Drug Prices

CMS building
CMS said planned Medicare Part B premium increases are partly the result of the proposed lump sum payment for previous illegal 340B hospital cuts.

The U.S. Centers for Medicare & Medicaid Services Tuesday announced the first 27 prescription drugs that will be subject to Medicare Part B inflation rebates, a list that includes AbbVie’s blockbuster arthritis drug Humira, which generated $5.6 billion in global

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live